3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
14
Triple Negative Breast Neoplasms
5
Neoplasm Metastasis
3
Urinary Bladder Neoplasms
2
Urethral Neoplasms
1
Ureteral Neoplasms
1
Refractory Solid Tumors
1
Liposarcoma
1
HR+HER2- Breast Cancer
1
Carcinoma, Transitional Cell
1
Interventions
Doxorubicin
14
pembrolizumab
11
Specimen Handling
11
Magnetic Resonance Spectroscopy
10
Biopsy
9
Cyclophosphamide
8
X-Rays
7
Radiotherapy
7
Nivolumab
7
Ifosfamide
7
Phantoms, Imaging
6
Gemcitabine
6
liposomal doxorubicin
5
Temozolomide
5
Radiation
5
tazemetostat
4
palbociclib
4
Trabectedin
4
Nuclear Medicine Department, Hospital
4
Irinotecan
4
Ipilimumab
4
pazopanib
3
larotrectinib
3
fludarabine
3
cabozantinib
3
atezolizumab
3
Surveys and Questionnaires
3
Radiation Dose Hypofractionation
3
Proton Therapy
3
Carboplatin
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Sarcoma
×
eribulin
×
90 days
×
Clear all
No trials found.